Loading…
Based on limited metadata with no full letter text available, CV7 Holdings LLC received an FDA Warning Letter on May 18, 2018, regarding products classified as "Other" by the agency. Without access to the subject line or specific violation details, the exact nature of the regulatory concerns cannot be determined from this metadata alone. The issuing office information is also unavailable, limiting clarity on which FDA center initiated the action. A review of the complete Warning Letter would be necessary to identify the specific products involved and the regulatory violations cited.